The acute angiogenic signalling response to low-load resistance exercise with blood flow restriction

Eur J Sport Sci. 2018 Apr;18(3):397-406. doi: 10.1080/17461391.2017.1422281. Epub 2018 Jan 17.

Abstract

This study investigated protein kinase activation and gene expression of angiogenic factors in response to low-load resistance exercise with or without blood flow restriction (BFR). In a repeated measures cross-over design, six males performed four sets of bilateral knee extension exercise at 20% 1RM (reps per set = 30:15:15:continued to fatigue) with BFR (110 mmHg) and without (CON). Muscle biopsies were obtained from the vastus lateralis before, 2 and 4 h post-exercise. mRNA expression was determined using real-time RT-PCR. Protein phosphorylation/expression was determined using Western blot. p38MAPK phosphorylation was greater (p = 0.05) at 2 h following BFR (1.3 ± 0.8) compared to CON (0.4 ± 0.3). AMPK phosphorylation remained unchanged. PGC-1α mRNA expression increased at 2 h (5.9 ± 1.3 vs. 2.1 ± 0.8; p = 0.03) and 4 h (3.2 ± 0.8 vs. 1.5 ± 0.4; p = 0.03) following BFR exercise with no change in CON. PGC-1α protein expression did not change following either exercise. BFR exercise enhanced mRNA expression of vascular endothelial growth factor (VEGF) at 2 h (5.2 ± 2.8 vs 1.7 ± 1.1; p = .02) and 4 h (6.8 ± 4.9 vs. 2.5 ± 2.7; p = .01) compared to CON. mRNA expression of VEGF-R2 and hypoxia-inducible factor 1α increased following BFR exercise but only eNOS were enhanced relative to CON. Matrix metalloproteinase-9 mRNA expression was not altered in response to either exercise. Acute low-load resistance exercise with BFR provides a targeted angiogenic response potentially mediated through enhanced ischaemic and shear stress stimuli.

Keywords: BFR; capillaries; hypoxia; kaatsu; resistance training.

MeSH terms

  • Adult
  • Cross-Over Studies
  • Exercise / physiology*
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit / metabolism
  • Ischemia
  • Male
  • Matrix Metalloproteinase 9 / metabolism
  • Neovascularization, Physiologic*
  • Nitric Oxide Synthase Type III / metabolism
  • Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha / metabolism
  • Protein Kinases / metabolism*
  • Quadriceps Muscle / physiology*
  • Regional Blood Flow
  • Resistance Training*
  • Vascular Endothelial Growth Factor A / metabolism
  • Vascular Endothelial Growth Factor Receptor-2 / metabolism
  • Young Adult
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • HIF1A protein, human
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • PPARGC1A protein, human
  • Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • NOS3 protein, human
  • Nitric Oxide Synthase Type III
  • Protein Kinases
  • KDR protein, human
  • Vascular Endothelial Growth Factor Receptor-2
  • p38 Mitogen-Activated Protein Kinases
  • MMP9 protein, human
  • Matrix Metalloproteinase 9